Prestige Brands Holdings, Inc. — Form 10-Q Summary
Issuer note: The filing identifies the registrant as Prestige Brands Holdings, Inc.; the request metadata names Prestige Consumer Healthcare Inc. The filing covers the fiscal third quarter and nine months ended December 31, 2017, for the fiscal year ending March 31, 2018. The company sells OTC healthcare and household-cleaning products.
Financial performance
| Metric | Three months ended Dec. 31, 2017 | Three months ended Dec. 31, 2016 | Nine months ended Dec. 31, 2017 | Nine months ended Dec. 31, 2016 |
|---|---|---|---|---|
| Total revenue | $270.6 million | $216.8 million | $785.2 million | $641.4 million |
| Gross profit | $147.7 million | $124.5 million | $435.2 million | $370.1 million |
| Gross margin | 54.6% | 57.5% | 55.4% | 57.7% |
| Operating income | $83.5 million | $69.3 million | $238.7 million | $152.6 million |
| Interest expense, net | $25.9 million | $18.6 million | $79.0 million | $60.5 million |
| Net income | $314.8 million | $31.6 million | $379.3 million | $58.3 million |
| Diluted EPS | $5.88 | $0.59 | $7.08 | $1.09 |
| Operating cash flow | Not presented for the quarter | Not presented for the quarter | $155.7 million | $141.1 million |
At December 31, 2017, cash was $45.4 million; total current assets were $332.1 million and current liabilities were $151.5 million. Principal debt was $2.077 billion ($2.053 billion net of unamortized debt costs), including $70 million drawn on the revolving facility, with $95.9 million of additional revolver capacity. Cash increased $3.5 million from March 31, 2017. Nine-month capital spending was $9.7 million.
Changes versus prior comparable periods
- Revenue increased 24.8% for the quarter and 22.4% for the nine-month period. Fleet, acquired in January 2017, contributed $54.1 million and $160.7 million of revenue, respectively; divestitures reduced revenue by $5.9 million and $22.9 million. Excluding acquisitions and divestitures, revenue increased $5.7 million for the quarter and $6.0 million for the nine months.
- OTC healthcare growth was partly offset by Household Cleaning revenue declines of 8.7% for the quarter and 8.6% for the nine months. Management cited weaker Comet sales; nine-month results also reflected the earlier sale of certain Comet royalty rights.
- Gross margin declined in both periods, which management attributed primarily to higher distribution costs and Fleet’s lower margins. Household Cleaning gross profit and contribution margin also fell materially.
- Operating income increased, but interest expense rose as average debt increased following the Fleet acquisition. Average borrowing costs declined to 4.9% from 5.1% for the quarter and from 5.3% for the nine months.
- Prior-year nine-month results included a $51.6 million pre-tax net loss on divestitures; this was absent in the current period.
Outlook, risks and unusual items
- Net income includes a one-time $281.2 million gain from remeasuring deferred tax liabilities under the Tax Cuts and Jobs Act, partly offset by a $3.0 million deemed-repatriation tax charge. The company cautioned that final tax impacts could differ materially. It estimated an approximately 35.3% effective tax rate for the remaining fiscal 2018 quarter, excluding discrete items.
- Management said operating cash flow and existing credit facilities were expected to fund working capital and capital expenditures for the next 12 months, excluding acquisitions, while noting there was no assurance. It anticipated covenant compliance for the remainder of fiscal 2018 and reported compliance at December 31, 2017.
- The company reported no goodwill or intangible-asset impairment indicators at December 31, 2017. These assets comprise a substantial portion of total assets, and management noted that weaker sales or margins, competition, consumer trends, and other changes could prompt future impairment.
- Key disclosed risks include substantial debt and variable-rate exposure, customer concentration, reliance on third-party manufacturers and a third-party distribution center, input-cost inflation, competition and pricing pressure, acquisition integration, product liability and regulatory matters. Walmart represented 21.4% of quarterly and 24.0% of nine-month gross revenue; Walmart and Walgreens together represented 33.4% of receivables at period-end.
- A 1% increase in rates on $1.327 billion of variable-rate debt was estimated to reduce pre-tax earnings and cash flow by approximately $3.4 million for the quarter and $10.6 million for the nine months. Disclosure controls were deemed effective; Fleet was excluded from the internal-control assessment while integration work continued.
Important facts for investors to verify
- Confirm the correct issuer identity, given the difference between the request metadata and the registrant named in the filing.
- Assess underlying revenue and margin trends apart from Fleet’s contribution and divested brands, especially Household Cleaning and Comet.
- Separate the $281.2 million tax-related one-time gain from recurring earnings and monitor final Tax Act measurement adjustments.
- Review debt repayment capacity, covenant headroom, refinancing needs, and sensitivity to interest rates.
- Monitor customer concentration, supplier and distribution continuity, and the effect of rising manufacturing, freight, and raw-material costs.